CORRELATION BETWEEN SPECIFIC GENETIC MUTATIONS AND COLISTIN - - PowerPoint PPT Presentation
CORRELATION BETWEEN SPECIFIC GENETIC MUTATIONS AND COLISTIN - - PowerPoint PPT Presentation
AN INVESTIGATION INTO THE CORRELATION BETWEEN SPECIFIC GENETIC MUTATIONS AND COLISTIN RESISTANCE IN ESCHERICHIA COLI Leisha McGrath B.Sc.(Hons.) in Medical Science Galway-Mayo Institute of Technology University College Dublin-Centre for Food
BACKGROUND OF COLISTIN
- Last line of defence for treating multi-drug resistant Gram
negative bacterial infections
- Cationic polypeptide with a fatty acid chain attached
- Targets the lipopolysaccharide molecule
- Use in human medicine becoming more common
COLISTIN IN MEDICINE
- Manufactured as colistin sulfate or colistimethate sodium
- Colistin sulfate used in bowel decontamination and treating
surface infections
- Colistimethate sodium used to treat MDR Pseudomonas
aeruginosa infections in cystic fibrosis patients
- Associated with nephrotoxicity and neurotoxicity
CHROMOSOMAL COLISTIN RESISTANCE
Low [Mg2+] High [Fe3+]
Figure 1: Colistin resistance mechanisms (1)
PROJECT METHODOLOGIES
- 1. Microbroth Dilution to investigate antibiotic
minimum inhibitory concentrations
- 2. Lambda Red Recombination for deleting
phoP from E. coli ATCC 25922 genome
- 1. MICROBROTH DILUTION
Antibiotic conc. (Mg/l) S.C. G.C. 0.0156 0.0313 0.0625 0.125 0.25 0.5 1 2 4 8 Well No. 1 2 3 4 5 6 7 8 9 10 11 12 M6 M73 M33 M52 M4 M44 Control ATCC 25922
Table 1: Schematic table of microbroth dilution method
- 2. LAMBDA RED RECOMBINATION
Figure 2: Schematic demonstrating Lambda Red Recombination (2)
Isolate mcr-1 Status of Isolate Colistin MIC Interpretation
M6 mcr-1 negative RESISTANT M73 mcr-1 negative RESISTANT M33 mcr-1 positive LOW LEVEL RESISTANCE M52 mcr-1 positive SENSITIVE M4 mcr-1 negative SENSITIVE M44 mcr-1 negative SENSITIVE Control ATCC 25922 mcr-1 negative SENSITIVE
Table 2: mcr-1 status and colistin MIC interpretation of E. coli test isolates and control strain
VERIFICATION OF phoP DELETION
Figure 4: Electrophoresis demonstrating the presence of kanamycin resistance cassette in Well 2 and phoP in Wells 2 and 4
VERIFICATION OF KRC DELETION
Figure 5: Electrophoresis graph demonstrating the successful deletion of the KRC from mutant E. coli ATCC 25922
Colistin MIC (mg/l) Interpretation Wild type E. coli ATCC 25922 0.125 SENSITIVE Mutant E. coli ATCC 25922 0.25 SENSITIVE Table 3: Colistin MIC of wild type E. coli ATCC control strain and mutant control strain
CONCLUSION
- One fold increase in MIC value is significant
- Demonstrates other two-component systems compensate
for loss of phoP upon colistin exposure
- Also implies phoP mutation alone cannot mediate colistin
resistance
- Multiple mutations in two-component systems are required
for the development of a colistin resistant phenotype
FUTURE WORK
- Clone mcr-1 into:
- Susceptible E. coli control strain ATCC 25922
- Mutant E. coli ATCC 25922
- Investigate the true function of the mcr-1 gene – does it
actually confer colistin resistance or serve to augment colistin resistance mechanisms?
REFERENCES
- (1) Olaitan AO, Morand S, Rolain J-M. Mechanisms of
polymyxin resistance: acquired and intrinsic resistance in
- bacteria. Frontiers in Microbiology. 2014; 5: 634.
- (2) Datsenko KA, Wanner BL. One-step inactivation of
chromosomal genes in Escherichia coli K-12 using PCR
- products. Proceedings of the National Academy of
Sciences of the United States of America. 2000; 97(12): 6640 – 6645.
ACKNOWLEDGEMENTS
I would like to sincerely thank:
- Professor Séamus Fanning, Director of the UCD Centre for
Food Safety and Principle Investigator of this project, for his guidance and advice during this research project
- Evan Brennan and Dr. Shabarinath Srikumar, researchers in
UCD Centre for Food Safety for their help in both the theoretical and practical aspects of this project
- Dr. Debbie Corcoran, Galway-Mayo Institute of Technology